PolyMVA

Considered a “metallo-vitamin”

      • Poly = Palladium Lipoic Acid Complex (Pdla)
      • M = Minerals
      • V = Vitamins
      • A = Amino Acid

PolyMVA is a unique liquid dietary supplement designed to support and promote cellular energy production. It contains various minerals, B complex vitamins, palladium, and amino acids and lipoic acid – molybdenum, rhodium, ruthenium, thiamine, riboflavin, cyanocobalamin, acetyl cysteine, and formyl methionine.PolyMVA can be taken orally or administered via intravenous infusion. Intravenous infusions have been found to be and safe and tolerable with minimal side effects. Intravenous infusions take approximately 30 to 45 minutes.

 PdLA (Palladium Lipoic Acid Complex):

      • Most active ingredient
      • Is a trimer of  the element palladium (rare metal mw 106)
      • Palladium is irreversibly covalently bound to alpha-lipoic acid around a Thiamine core

History of PolyMVA

      • Poly-MVA was created by Merrill Garnett, DDS, a former dentist with some graduate training in biochemistry.
      • Conducted research in “electrogenetics” since the late 1950s at different laboratories on Long Island, New York.
      • Is the founder and director of the Garnett McKeen Laboratory, which continues to study Poly-MVA and similar compounds.

Mode of Action:

      • Palladium allows lipoic acid to reach cells in the body it could not otherwise reach. The other components of Poly-MVA complement these actions and to help restore nutrients needed for energy.
      • Is an antioxidant, boosts the immune system, reduces pain, and helps regain energy and appetite
      • In patients with cancer, Poly-MVA may improve quality of life, especially in those undergoing chemotherapy or radiation therapy and may lead to longer survival
      • Promotes cell death in cancer cells. Cancer cells rely mainly on sugar and anaerobic glycolysis as their primary source of energy – Poly-MVA decreases HIF (Hypoxia Inducing Factor) levels leading to less glycolysis thereby depriving cancer cells of energy, causing them to undergo apoptosis
      • Is also useful in other conditions, including asthma, psoriasis, chronic fatigue syndrome, and AIDS.
      • Provides energy to healthy cells
      • Provides potent Liver Support
      • Removes heavy metals from the bloodstream
      • Promotes immune and nerve function, production of nerve myelin sheath and  red blood cell production

Studies: 

      • Dr. James W. Forsythe M.D., H.M.D. performed an outcome-based investigation on various Stage IV Cancers with Poly-MVA which began in January of 2004 in Reno, Nevada. 207 patients enlisted in the study with a 56% overall positive response rate
      • KGK Synergize Inc., an independent laboratory in Canada found Poly-MVA to be effective on 8 different cell lines:
        • Skin melanoma, human (SKMel-5)
        • Liver, hepatocellular carcinoma, human (Hep G2)
        • Lung, malignant melanoma, human (Malme-3M)
        • Mammary gland, ductal carcinoma, human (MDA-MB 435)
        • Prostate, left supraclavicular lymph node carcinoma, human (LNCaP)
        • Colon, colorectal adenocarcinoma, human (HT-29)
        • Human brain, glioblastoma; astrocytoma (U87
      • Studies at a U.S. research university examined the non-toxic chemotherapeutic effects of Poly-MVA on brain and breast tumors. Separately, ischemia studies in animals demonstrated that acute, post-ischemic and prophylactic administration of Poly-MVA limits ischemic damage.
      • Preclinical studies with Poly-MVA were performed independently at Calvert Laboratories, Inc. to determine its effectiveness in halting the growth of glioblastoma cells in vivo. Significantly reduced growth of the glioblastoma (50% or greater reduction in tumor size) was noted.
      • The Scientific Resource Booklet from Garnett-McKeen Labs shows Poly-MVA as safe and effective with cellular energy, cancer and ischemia.
      • Prostate and lung cancer case studies have been tracked, analyzed, written up and published by Dr. Shari Lieberman, et al. – www.facr.org
      • In animal studies, PolyMVA showed effects in improving both ischemic myocardial and diabetic outcomes

References: